People · Operator
Named in public records as an officer, director or promoter · active 2016–2024 · Healthtech, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Preceptis Medical, Inc. | — | Healthtech | Series A | $21.3M | $8.3M | 2018 |
| Qurgen Inc. | — | Biotechnology | Series A | $9.7M | $162.7M | 2016 |
Feng Jiang at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Feng Jiang on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Steve Anderson | 1 | 14 |
| Mark Wagner | 1 | 9 |
| Buzz Benson | 1 | 8 |
| John Seaberg | 1 | 5 |
| JOE DELGADO | 1 | 3 |
| Christopher Geyen | 1 | 3 |
| Michael Dale | 1 | 3 |
| Michael Chopp | 1 | 1 |
| David Overman | 1 | 1 |
| Zhaohua Yuan | 1 | 1 |
| Jianguo Wang | 1 | 1 |
| Michael Loushin | 1 | 1 |
| Toni Baraga | 1 | 1 |
| Thomas Vettel | 1 | 1 |
| Jianjun Wang | 1 | 1 |
| Qianqian Li | 1 | 1 |
| Ming Guo | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.